Detection of the Tim-3 ligand, galectin-9, inside the allograft during a rejection episode

International Immunopharmacology

Volumn 9, Issue 6, 2009, Pages 658-662

  Naka, Erika Lamkowski ^a   Ponciano, Viviane Campos ^a   Cenedeze, Marcos Antônio ^a   Pacheco Silva, Alvaro ^a,c   Saraiva Câmara, Niels Olsen ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Acute rejection; Galectin 9; Kidney transplantation; Tim 3

Indexed keywords

CELL MEMBRANE PROTEIN; ECALECTIN; GAMMA INTERFERON; GRANZYME B; MESSENGER RNA; PERFORIN; PROTEIN TIM 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL;

ADULT; FEMALE; GALECTINS; GRAFT REJECTION; GRANZYMES; HUMANS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PERFORIN; TRANSPLANTATION, HOMOLOGOUS;

EID: 65349103948     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.11.013     Document Type: Article

References (23)

1. Halloran P.F. Immunosuppressive drugs for kidney transplantation. N Engl J Med 351 26 (2004) 2715-2729
2. Marleau A.M., and Sarvetnick N. T cell homeostasis in tolerance and immunity. J Leukoc Biol 78 3 (2005) 575-584
3. Zheng X.X., Sanchez-Fueyo A., Domenig C., and Strom T.B. The balance of deletion and regulation in allograft tolerance. Immunol Rev 196 (2003 Dec) 75-84
4. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415 (2002) 536-541
5. Sabatos C.A., Chakravarti S., Cha E., Schubart A., Sánchez-Fueyo A., Zheng X.X., et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 4 (2003) 1102-1110
6. Ilarregui J.M., Bianco G.A., Toscano M.A., and Rabinovich G.A. The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders. Ann Rheum Dis 64 Suppl 4 (2005) 96-103
7. Rabinovich G.A., Liu F.T., Hirashima M., and Anderson A. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol 66 2-3 (2007) 143-158
8. Wada J., and Kanwar Y.S. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem 272 9 (1997) 6078-6086
9. Imaizumi T., Kumagai M., Sasaki N., Kurotaki H., Mori F., Seki M., et al. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol 72 3 (2002) 486-491
10. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6 12 (2005) 1245-1252
11. Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 2 (1999) 713-723
12. Strehlau J., Pavlakis M., Lipman M., Shapiro M., Vasconcellos L., Harmon W., et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 94 2 (1997) 695-700
13. Vasconcellos L.M., Schachter A.D., Zheng X.X., Vasconcellos L.H., Shapiro M., Harmon W.E., et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 66 5 (1998) 562-566
14. Li B., Hartono C., Ding R., Sharma V.K., Ramaswamy R., Qian B., et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 344 13 (2001) 947-954
15. Galante N.Z., Câmara N.O., Kallas E.G., Salomão R., Pacheco-Silva A., and Medina-Pestana J.O. Noninvasive immune monitoring assessed by flow cytometry and real time RT-PCR in urine of renal transplantation recipients. Transpl Immunol 16 2 (2006) 73-80
16. Renesto P.G., Ponciano V.C., Cenedeze M.A., Saraiva Câmara N.O., and Pacheco-Silva A. High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am J Transplant 7 6 (2007) 1661-1665
17. Ponciano V.C., Renesto P.G., Nogueira E., Rangel E.B., Cenedeze M.A., Franco M.F., et al. Tim-3 expression in human kidney allografts. Transpl Immunol 17 3 (2007) 215-222
18. Sánchez-Fueyo A., Tian J., Picarella D., Domenig C., Zheng X.X., Sabatos C.A., et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4 11 (2003 Nov) 1093-1101
19. Hirashima M., Kashio Y., Nishi N., Yamauchi A., Imaizumi T.A., Kageshita T., et al. Galectin-9 in physiological and pathological conditions. Glycoconj J 19 (2004) 593-600
20. Matsushita N., Nishi N., Seki M., Matsumoto R., Kuwabara I., Liu F.T., et al. Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J Biol Chem 275 (Mar 2000 24) 8355-8360
21. Asakura H., Kashio Y., Nakamura K., Seki M., Dai S., Shirato Y., et al. Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol 169 (2002 Nov 15) 5912-5918
22. Kageshita T., Kashio Y., Yamauchi A., Seki M., Abedin M.J., Nishi N., et al. Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 99 (Jun 2002 20) 809-816
23. Wada J., Ota K., Kumar A., Wallner E.I., and Kanwar Y.S. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 99 (1997 May 15) 2452-2461